Yahoo
NYSE - Delayed Quote USD

Teva Pharmaceutical Industries Limited (TEVA)

36.36 -0.26 (-0.71%)
At close: September 4 at 4:00:02 PM EDT
37.19 +0.83 (+2.28%)
After hours: September 4 at 7:59:01 PM EDT
Trade TEVA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
17,314,000
17,257,000
16,544,000
15,845,000
14,925,000
Cost of Revenue
8,232,000
8,320,000
8,481,000
8,200,000
7,952,000
Gross Profit
9,083,000
8,938,000
8,064,000
7,645,000
6,973,000
Operating Expense
5,842,000
4,986,000
4,700,000
4,451,000
4,283,000
Operating Income
3,241,000
3,952,000
3,364,000
3,194,000
2,690,000
Net Non Operating Interest Income Expense
-948,000
-985,000
-1,050,000
-1,095,000
-991,000
Other Income Expense
-1,585,000
-1,742,000
-3,597,000
-2,723,000
-4,859,000
Pretax Income
708,000
1,223,000
-1,284,000
-624,000
-3,163,000
Tax Provision
12,000
-180,000
676,000
-7,000
-643,000
Earnings from Equity Interest Net of Tax
13,000
15,000
1,000
2,000
21,000
Net Income Common Stockholders
706,000
1,410,000
-1,639,000
-559,000
-2,446,000
Diluted NI Available to Com Stockholders
706,000
1,410,000
-1,639,000
-559,000
-2,446,000
Basic EPS
0.62
1.23
-1.45
-0.50
-2.12
Diluted EPS
0.60
1.21
-1.45
-0.50
-2.12
Basic Average Shares
1,154,000
1,145,000
1,131,000
1,119,000
1,110,000
Diluted Average Shares
1,163,500
1,163,000
1,131,000
1,119,000
1,110,000
Total Operating Income as Reported
1,603,000
2,157,000
-303,000
433,000
-2,197,000
Total Expenses
14,074,000
13,306,000
13,181,000
12,651,000
12,235,000
Net Income from Continuing & Discontinued Operation
706,000
1,410,000
-1,639,000
-559,000
-2,446,000
Normalized Income
2,304,440.68
2,752,110
1,138,390
2,127,860
1,420,400
Interest Expense
897,000
916,000
1,002,000
1,029,000
930,000
Net Interest Income
-948,000
-985,000
-1,050,000
-1,095,000
-991,000
EBIT
1,605,000
2,139,000
-282,000
405,000
-2,233,000
EBITDA
2,593,000
3,141,000
777,000
1,558,000
-925,000
Reconciled Cost of Revenue
8,232,000
8,320,000
8,481,000
8,200,000
7,952,000
Reconciled Depreciation
988,000
1,002,000
1,059,000
1,153,000
1,308,000
Net Income from Continuing Operation Net Minority Interest
706,000
1,410,000
-1,639,000
-559,000
-2,446,000
Total Unusual Items Excluding Goodwill
-1,626,000
-1,743,000
-3,607,000
-2,714,000
-4,833,000
Total Unusual Items
-1,626,000
-1,743,000
-3,607,000
-2,714,000
-4,833,000
Normalized EBITDA
4,219,000
4,884,000
4,384,000
4,272,000
3,908,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-27,559.32
-400,890
-829,610
-27,140
-966,600
12/31/2022 - 2/16/1982

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: